Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Tetra Bio Pharma Inc
TBPMQ
Healthcare
Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to...
advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
GREY:TBPMQ - Post Discussion
Tetra Bio Pharma Inc
> What's happening Golddetector ? Please update us all !
New Post
View:
Discussion
List
(58)
•••
SamV21
X
View Profile
View Bullboard History
Post by
SamV21
on Sep 09, 2023 11:45am
What's happening Golddetector ? Please update us all !
Keep dreaming and wasting shareholders money Phase 1
AUSTIN, Texas
,
April 26, 2022
/PRNewswire/ --
Direct Biologics
, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo, to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19. Direct Biologics is the first and only EV company to receive FDA Phase 3 approval for an Investigational New Drug (IND) indication to date.
Once again Guy is in lala land , he will never catch up to real world science , all these dreams take time and money which Tetra has neither .Stock will never trade again if Guy has his way , some private company will buy Tetra and shareholders will be left with nothing, its all about Guy and HIS science that he spent our money on over the years , go back and read the news releases saying revenue next year , he promised to be selling Reduvo by the end of 2021 . This phase 1 study has not even started yet , product is worth nothing till Phase 3 and that will be 10 years away. Wake up , dreamer .Direct Biologics is only one companies in the Ards race, there are many others in Phase 3 development with deep pockets to fund their research and solid medical Dr.s behind them .Guy is a general contractor putting deals together to keep his over paid wage going , when the company is moved to a private Inc. company shareholders will be left with nothing and Guy will continue with the renamed privately held Inc. perhaps his own 93154466 Quebec Inc. I really hope I am wrong but the pattern of lies, performance and truthful communication and lack there of by Guy and Tetra screams , here we go again more dead end money . I have called the re/max realtor in Ontario that has the building for lease where Tetra's office should be in Ontario last year and was told the whole building was empty and for lease. So Tetra mail is most likely just being forwarded to his residence.
160,000,000 deficit
460,000,000 outstanding shares dilutted to death , sold off piece by piece
Upcoming promised payments to Panag Pharma 1,200.000 every year till 2029 if payments are not made 15,000,000 becomes due ( read page 31 in your magagement's discussion and Analysis from August 2022 ) page 32 another 13,800,999 due , 1,000,000 to Lumiea Health Innovations Inc , I think Guy had his private company connected to that deal, Debenture another 3,000,000
I haven't even touched on the over 1,500,000 annual interest paid out.
Have we spent your 4,500,000 yet ?
Broke is broke , Guy doesn't function in reality for Tetra and its shareholders , never has and never will, that is why we are halted , shareholders didn't cause the halt Guy the CEO did.
Too bad no one wanted to discuss reality of the situation here , perhaps we could have stopped the CEO money sucking machine years ago and held Guy and TBP accountable .
I guess we just didn't Believe hard enough in unicorn farts and fairy dust because thats all that Guy and TBP was !
(1)
•••
jeano55
X
View Profile
View Bullboard History
Comment by
jeano55
on Sep 12, 2023 11:19am
Hi all. Sam was totally right from the begining to the end ! all pumpers ave...vanished. one last question : can I claim loss in my taxes following tbp bankruptcy ? what is the process since I have bouht my 90 000 shares via my bank. Thanks!
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income